Global law firm Freshfields Bruckhaus Deringer (‘Freshfields’) is advising global healthcare group Fresenius on its divestment of fertility services provider Eugin Group to a consortium of global fertility group IVI RMA (a KKR portfolio company) and GED Capital for up to € 500 million including earn-outs. The transaction is subject to regulatory approvals. Headquartered in […]
The post Freshfields advising Fresenius on its divestment of Eugin Group to consortium led by KKR portfolio company IVI RMA appeared first on Legal Desire Media and Insights.